After-Hours Stock Movers:
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP)23.4% HIGHER; announced that it has entered into a worldwide exclusive licensing agreement with UNION therapeutics A/S (UNION) for its TFF technology used in combination with niclosamide.
Paysign, Inc. (NASDAQ: PAYS)22% LOWER; reports Q2 results
iQIYI (NASDAQ: IQ)17.4% LOWER; reported Q2 EPS of ($0.28), $0.21 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $1 billion versus the consensus estimate of $1.05 billion. SEC investigation.
Co-Diagnostics (NASDAQ: CODX)16.6% LOWER; reported Q2 EPS of $0.43, $0.16 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $24.04 million versus the consensus estimate of $26.45 million.
Equillium, Inc. (Nasdaq: EQ)16% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering
Dillard's (NYSE: DDS)15.4% HIGHER; reported Q2 EPS of ($0.37), $4.17 better than the analyst estimate of ($4.54). Revenue for the quarter came in at $919 million versus the consensus estimate of $1.01 billion.
Blink Charging (NASDAQ: BLNK)13% HIGHER; reported Q2 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $2.9 million versus the consensus estimate of $1.23 million.
Purple Innovation (NASDAQ: PRPL)10.4% LOWER; reported Q2 EPS of ($0.11), $0.30 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $165.1 million versus the consensus estimate of $175.88 million.
Optinose (NASDAQ: OPTN)10% LOWER; announced the commencement of a proposed underwritten public offering of shares of its common stock. All of the shares of common stock will be offered by Optinose. Optinose expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the total number of shares of common stock.
Farfetch Limited (NYSE: FTCH)9.6% HIGHER; reported Q2 EPS of ($0.20), $0.15 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $364.7 million versus the consensus estimate of $326.92 million.
Baidu.com (NASDAQ: BIDU)7.5% LOWER; reported Q2 EPS of $1.46, $0.08 better than the analyst estimate of $1.38. Revenue for the quarter came in at $3.69 billion versus the consensus estimate of $3.7 billion. Baidu.com sees Q3 2020 revenue of $3.7-4.1 billion, versus the consensus of $3.97 billion.
Baidu.com (NASDAQ: BIDU)7.5% LOWER; reported Q2 EPS of $1.46, $0.08 better than the analyst estimate of $1.38. Revenue for the quarter came in at $3.69 billion versus the consensus estimate of $3.7 billion. Baidu.com sees Q3 2020 revenue of $3.7-4.1 billion, versus the consensus of $3.97 billion.
Precigen, Inc. (NASDAQ: PGEN)4.6% HIGHER; sees insider buying
Applied Materials (NASDAQ: AMAT)2.6% HIGHER; reported Q3 EPS of $1.06, $0.11 better than the analyst estimate of $0.95. Revenue for the quarter came in at $4.4 billion versus the consensus estimate of $4.18 billion. Applied Materials sees Q4 2020 EPS of $1.11-$1.23, versus the consensus of $1.02. Applied Materials sees Q4 2020 revenue of $4.4-4.6 billion, versus the consensus of $4.36 billion.